ACTIVE

STERIGENICS BELGIUM (FLEURUS)

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result6,1 M €-3,9 %over 1 year

Revenue18,4 M €+1,7 %over 1 year

Equity14,7 M €+15,4 %over 1 year

Workforce45,7 ETP-3,8 %over 1 year

Identity

Source · BCE/KBO

STERIGENICS BELGIUM (FLEURUS) is a Private limited company incorporated in 1990. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Fleurus. It employs on average 45,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0442.042.064
Incorporation: 26/11/1990
Legal form: Private limited company
Registered office: Avenue de l'Espérance(F) 17
6220 Fleurus · WallonieSee on map
Contributed capital: 5 834 000,00 €
Latest accounts: 31/12/2025
Average workforce: 45,7 ETP

Activities (NACE)

74700Other professional, scientific and technical activities· main 81220Other building and industrial cleaning activities 81220Other building and industrial cleaning activities 82920Packaging activities 82920Packaging activities

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 5 financial years

	2025		2024		2023		2022		2020
Income statement
Revenue	18,4 M €	+1.7%	18,1 M €	+3.7%	17,5 M €	+22.3%	14,3 M €	+47.2%	9,7 M €
EBITDA	9,7 M €	-2.0%	9,8 M €	-2.5%	10,1 M €	+41.9%	7,1 M €	+78.2%	4 M €
Operating result	8,1 M €	-3.7%	8,4 M €	-5.3%	8,9 M €	+53.0%	5,8 M €	+83.7%	3,2 M €
Net result	6,1 M €	-3.9%	6,3 M €	-3.6%	6,5 M €	+53.8%	4,3 M €	+82.4%	2,3 M €
Balance sheet
Equity	14,7 M €	+15.4%	12,7 M €	-39.6%	21,1 M €	+45.1%	14,5 M €	+96.7%	7,4 M €
Total assets	16,4 M €	+13.1%	14,5 M €	-38.0%	23,4 M €	+41.4%	16,5 M €	+94.0%	8,5 M €
Cash	465,2 €	-55.7%	1,1 k €	-5.0%	1,1 k €	+266%	302,3 €	-53.6%	651,4 €
Debts	948,6 k €	-9.0%	1 M €	-34.5%	1,6 M €	+23.0%	1,3 M €	+82.2%	709,6 k €
Other
Workforce	45,7 ETP	-3.8%	47,5 ETP	+5.3%	45,1 ETP	+7.1%	42,1 ETP	+7.4%	39,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Robin Van Den Bergh	Director22/07/2025 → 30/06/2031
Giuseppe Ritaccio	Director01/07/2020 → 30/06/2026
Lars Pontus Rundstrom	Director01/07/2020 → 30/06/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Eric Meyers	Director30/10/2014 → 15/07/2020
Frédéric Bekaert	Director02/07/2012 → 15/07/2020

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/07/2026	07/07/2025	30/08/2024	27/09/2023	27/07/2022	28/07/2021
General meeting	30/06/2026	30/06/2025	26/08/2024	13/09/2023	15/07/2022	15/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	23/07/2026	French	PDF
Full model	31/12/2024	30/06/2025	07/07/2025	French	PDF
Full model	31/12/2023	26/08/2024	30/08/2024	French	PDF
Full model	31/12/2022	13/09/2023	27/09/2023	French	PDF
Full model	31/12/2021	15/07/2022	27/07/2022	French	PDF
Full model	31/12/2020	15/07/2021	28/07/2021	French	PDF
Full model	31/12/2019	15/07/2020	31/07/2020	French	PDF
Full model	31/12/2018	05/07/2019	08/07/2019	French	PDF
Full model	31/12/2017	06/06/2018	17/08/2018	French	PDF
Full model	31/12/2016	07/06/2017	26/07/2017	French	PDF
Full model	31/12/2015	01/06/2016	27/07/2016	French	PDF
Full modelCorrection	31/12/2014	02/06/2015	08/10/2015	French	PDF
Full model	31/12/2014	02/06/2015	24/07/2015	French	PDF
Full model	31/12/2013	30/10/2014	21/11/2014	French	PDF
Full model	31/12/2012	28/02/2014	26/03/2014	French	PDF
Full model	31/12/2011	29/06/2012	05/07/2012	French	PDF
Full model	31/12/2010	29/06/2011	28/07/2011	French	PDF
Full model	31/12/2009	29/06/2010	23/07/2010	French	PDF
Full model	31/12/2008	26/06/2009	29/07/2009	French	PDF
Full model	31/12/2007	25/06/2008	24/07/2008	French	PDF
Full model	31/12/2006	27/06/2007	25/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 2 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Robin Van Den Bergh	Director22/07/2025 → 30/06/2031
Giuseppe Ritaccio	Director01/07/2020 → 30/06/2026
Lars Pontus Rundstrom	Director01/07/2020 → 30/06/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Eric Meyers	Director30/10/2014 → 15/07/2020
Frédéric Bekaert	Director02/07/2012 → 15/07/2020

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/08/2026
DEMISSIONS, NOMINATIONS, MODIFICATION FORME
PDF
Mandates09/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates30/12/2024
DEMISSIONS, NOMINATIONS
PDF
Registered office04/10/2021
SIEGE SOCIAL
PDF
Registered office20/04/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL
PDF
Registered office10/12/2020
SIEGE SOCIAL
PDF
Mandates22/10/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates20/07/2020
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings5 filings

Mandates

Robin Van Den Bergh

Giuseppe Ritaccio

Lars Pontus Rundstrom

Eric Meyers

Frédéric Bekaert

199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

STERIGENICS BELGIUM (FLEURUS)

Avenue de l'Espérance(F) 17, 6220 Fleurus

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue de l'Espérance(F) 17, 6220 FleurusCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00323445

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
STERIGENICS BELGIUM (FLEURUS)Current	accounts 2020 → 2025	Accounts 2025 · 2026-00323445

Events

2025
Annual accounts 20256,1 M €↓
2024
Annual accounts 20246,3 M €↓
2023
Annual accounts 20236,5 M €↑
2022
Annual accounts 20224,3 M €↑
2020
Annual accounts 20202,3 M €
26/11/1990
IncorporationPrivate limited company

STERIGENICS BELGIUM (FLEURUS)

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events